Yew Bio-Pharm Group, Inc. Selling Expense
Yew Bio-Pharm Group, Inc. reported Selling Expense of $16.96 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2018-11-19
- Yew Bio-Pharm Group, Inc. selling expense for the quarter ending 2018-09-30 was $16.96K, a 73.64% decline year-over-year.
- Yew Bio-Pharm Group, Inc. selling expense for the quarter ending 2018-06-30 was $6.99K, a 10489.39% increase year-over-year.
- Yew Bio-Pharm Group, Inc. selling expense for the quarter ending 2017-09-30 was $64.35K.
- Yew Bio-Pharm Group, Inc. selling expense for the quarter ending 2017-06-30 was $66.00.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month |
|---|---|---|---|
| 2018-09-30 | $16.96K 10-Q · filed 2018-11-19 | $23.95K derived: sum of 2 quarters · filed 2018-11-19 | $24.79K 10-Q · filed 2018-11-19 |
| 2018-06-30 | $6.99K 10-Q · filed 2018-08-14 | $7.83K 10-Q · filed 2018-08-14 | |
| 2017-09-30 | $64.35K 10-Q · filed 2018-11-19 | $64.41K derived: sum of 2 quarters · filed 2018-11-19 | $64.68K 10-Q · filed 2018-11-19 |
| 2017-06-30 | $66.00 10-Q · filed 2018-08-14 | $331.00 10-Q · filed 2018-08-14 |